Wang Ronghua 4
4 · Biostar Pharmaceuticals, Inc. · Filed Jun 10, 2011
Insider Transaction Report
Form 4
Wang Ronghua
DirectorChairman, CEO10% Owner
Transactions
- Purchase
Common Stock
2011-06-09$1.22/sh+12,000$14,665→ 9,061,973 total - Purchase
Common Stock
2011-06-08$1.26/sh+34,600$43,703→ 9,049,973 total
Footnotes (1)
- [F1]Purchase made pursuant to the stock repurchase plan of the Reporting Person as previously approved by the Board of Directors.